Safety, Contraindications, and Who Should Use Semaglutide Semaglutide is indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
Direct interactions are related primarily to gut radiation and microbiota homeostasis, while indirect interactions are more related to other axes, like the MGBA
This individualized approach enhances patient outcomes and satisfaction, leading to higher adherence and long-term success
But the nutritional outcomes are completely different
While diabetes primarily causes diabetic retinopathya distinct microvascular complicationsome epidemiological studies suggest diabetes may also influence AMD risk through shared pathophysiological mechanisms including chronic inflammation, oxidative stress, and endothelial dysfunction
Importantly, unlike monotherapy with pure glucagon agonists, retatrutide did not cause worsening of glycemic control the concurrent GLP-1 and GIP activity effectively offset any hyperglycemic tendency from glucagon receptor activation